4//SEC Filing
ROTHBLATT MARTINE A 4
Accession 0001106578-25-000042
CIK 0001082554other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:30 PM ET
Size
31.9 KB
Accession
0001106578-25-000042
Insider Transaction Report
Form 4
ROTHBLATT MARTINE A
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-17$120.26/sh+4,000$481,040→ 4,130 total - Sale
Common Stock
2025-12-17$500.52/sh−1,500$750,780→ 2,630 total - Sale
Common Stock
2025-12-17$501.35/sh−2,500$1,253,367→ 130 total - Exercise/Conversion
Common Stock
2025-12-18$120.26/sh+4,000$481,040→ 4,130 total - Sale
Common Stock
2025-12-18$507.24/sh−2,000$1,014,486→ 2,130 total - Sale
Common Stock
2025-12-18$509.42/sh−500$254,708→ 1,630 total - Sale
Common Stock
2025-12-18$510.86/sh−1,500$766,295→ 130 total - Exercise/Conversion
Common Stock
2025-12-19$120.26/sh+2,000$240,520→ 2,130 total - Sale
Common Stock
2025-12-19$505.45/sh−500$252,725→ 1,630 total - Sale
Common Stock
2025-12-19$507.61/sh−1,500$761,418→ 130 total - Exercise/Conversion
Stock Option
2025-12-17−4,000→ 6,000 totalExercise: $120.26From: 2020-03-15Exp: 2026-03-15→ Common Stock (4,000 underlying) - Exercise/Conversion
Stock Option
2025-12-18−4,000→ 2,000 totalExercise: $120.26From: 2020-03-15Exp: 2026-03-15→ Common Stock (4,000 underlying) - Exercise/Conversion
Stock Option
2025-12-19−2,000→ 0 totalExercise: $120.26From: 2020-03-15Exp: 2026-03-15→ Common Stock (2,000 underlying)
Holdings
- 166(indirect: By Spouse)
Common Stock
- 324,518(indirect: By Trust)
Common Stock
- 258,117(indirect: By Trust)
Common Stock
- 45,596(indirect: By Trust)
Common Stock
- 10,962(indirect: By Trust)
Common Stock
Footnotes (10)
- [F1]This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. The transactions reported on this Form 4 are the final trades under this plan.
- [F10]Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- [F2]This transaction was executed in multiple trades at prices ranging from $500.12 to $500.725. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $501.13 to $501.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $507.00 to $507.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $510.445 to $511.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $507.58 to $507.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- [F8]Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- [F9]Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001106578
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:30 PM ET
- Size
- 31.9 KB